Endogenous α2A-Adrenoceptor-Operated Sympathoadrenergic Tones Attenuate Insulin Secretion via cAMP/TRPM2 Signaling

Kiyonori Ito1, Katsuya Dezaki2, Masashi Yoshida1

  • 1First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.

Diabetes
|December 29, 2016
PubMed

Insights

Physiological adrenaline suppresses insulin release by activating α2A-adrenoceptors and TRPM2 channels in pancreatic beta cells. This pathway offers a potential therapeutic target for type 2 diabetes treatment.

Area of Science:

  • Endocrinology
  • Cell Physiology
  • Molecular Pharmacology

Background:

  • Adrenaline's role in physiological insulin regulation by pancreatic beta cells is poorly understood.
  • Nonselective cation channels (NSCCs) are implicated in glucose-induced insulin secretion.
  • Transient Receptor Potential Melastatin 2 (TRPM2) is a type of NSCC found in beta cells.

Purpose of the Study:

  • To investigate if physiological adrenaline action in beta cells is mediated by the TRPM2 channel.
  • To elucidate the signaling pathway linking adrenergic stimulation to insulin secretion inhibition.

Main Methods:

  • Electrophysiological recordings of NSCCs current in beta cells.
  • Measurement of cAMP production and insulin secretion in response to glucose and incretins.
  • Experiments using wild-type and TRPM2-knockout mice.
  • Assessment of glucose tolerance in vivo.

Main Results:

  • Physiological adrenaline suppressed glucose- and incretin-stimulated insulin secretion and cAMP production in wild-type mice.
  • Adrenaline inhibited NSCCs current and reduced beta cell membrane excitability via α2A-adrenoceptors.
  • TRPM2-knockout mice showed no suppression of insulin secretion by adrenaline.
  • α2A-adrenoceptor antagonist yohimbine improved glucose tolerance in wild-type but not TRPM2-knockout mice.

Conclusions:

  • Physiological adrenaline inhibits insulin release through a pathway involving α2A-adrenoceptor, cAMP, and TRPM2 channels in pancreatic beta cells.
  • This signaling axis represents a potential therapeutic target for managing type 2 diabetes.

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.8K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.9K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
4.2K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.4K
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.1K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.9K